Profile
BDXA ISRG BDX ALC RMD WST
Company Name Becton, Dickinson and Company Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. West Pharmaceutical Services, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $53.11B $183.74B $49.57B $44.11B $40.72B $17.20B
Employees 0.00K 15.64K 70.00K 25.60K 9.98K 10.60K
CEO - Gary S. Guthart Thomas E. Polen Jr. David J. Endicott Michael J. Farrell BE, MBA, SM Eric M. Green
Ratings
BDXA ISRG BDX ALC RMD WST
Quant Rating Score 5 3 3 3 4 2
Quant Rating Strong Buy Neutral Neutral Neutral Buy Sell
Trading
BDXA ISRG BDX ALC RMD WST
Last Close $59.24 $483.12 $176.37 $87.87 $279.2 $239.26
High 52 $59.24 $610.45 $249.08 $100.76 $279.2 $347.87
Low 52 $59.24 $438 $165.15 $82.73 $204.58 $190.39
Price vs. 52 Week High 0 % -20.86 % -29.19 % -12.79 % 0 % -31.22 %
Price vs. 52 Week Low 0 % 10.3 % 6.79 % 6.21 % 36.47 % 25.67 %
Total Return
BDXA ISRG BDX ALC RMD WST
1 Month Return 0 % -10.65 % -0.51 % -1.6 % 9.09 % 8.15 %
3 Month Return 0 % -8.75 % 4.5 % -10.61 % 16.36 % 13.24 %
6 Month Return 0 % -15.52 % -28.77 % -3.53 % 18.21 % -29.95 %
9 Month Return 0 % -4.59 % -25.03 % -4.27 % 14.3 % -24.4 %
YTD Return 0 % -7.44 % -22.26 % 3.51 % 22.09 % -26.96 %
1 Year Return 0 % 7.42 % -27.08 % -4.88 % 24.84 % -20.32 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDXA ISRG BDX ALC RMD WST
Dividend Yield Percentage (TTM) 2.28 % - 2.35 % 0.37 % 0.76 % 0.35 %
Dividend Paid and Capex Coverage Ration (TTM) 1.77 % 2.77 % 1.77 % 3.43 % 4.21 % 1.72 %
Dividend Per Share (TTM) 4.07 % - 4.07 % 0.33 % 2.12 % 0.84 %
Payout Ratio (TTM) 76.77 % - 76.77 % 11.23 % 23.14 % 12.32 %
Growth
BDXA ISRG BDX ALC RMD WST
Asset Growth 8.54 % 21.38 % 8.54 % 1.79 % -4.86 %
Gross Profit Growth 11.69 % 19.13 % 11.69 % 12.72 % -11.57 %
Revenue Growth 4.16 % 17.24 % 4.16 % 10.95 % -1.92 %
Revenue 3 Year -0.51 % 46.64 % -0.51 % 44.86 % 4.13 %
Revenue 5 Year 8.72 % 81.77 % 8.72 % 74.97 % 59.4 %
Revenue 10 Year 59.37 % 266.32 % 59.37 % 189.94 % 97.69 %
EBIT Growth 19.82 % 32.95 % 19.82 % 12.75 % -16.76 %
Net Income Growth 14.89 % 29.18 % 14.89 % 13.75 % -16.97 %
Net Income 3 Yeari Growth Per Share -18.63 % 36.6 % -18.63 % 112.66 % -24.12 %
Net Income 5 Yeari Growth Per Share 30.19 % 64.12 % 30.19 % 145.63 % 106.64 %
Net Income 10 Yeari Growth Per Share -4.02 % 418.52 % -4.02 % 184.54 % 276.5 %
Operating Income Growth 13.55 % 32.95 % 13.55 % 16.61 % -15.7 %
Operating Cash Flow Growth (CFG) 27.07 % 33.15 % 27.07 % 102.11 % -15.85 %
Operating 3 Year CFG -18.4 % 15.88 % -18.4 % 87.99 % 14.03 %
Operating 5 Year CFG 6.25 % 47.28 % 6.25 % 197.13 % 80.38 %
Operating 10 Year CFG 45.28 % 239.49 % 45.28 % 244.62 % 246.97 %
EPS Growth 18.31 % 27.71 % 18.31 % 13.4 % -15.52 %
EPS Diluted Growth 18.62 % 27.63 % 18.62 % 13.63 % -15.1 %
Book Value Per Share -0.85 % 21.99 % -0.85 % 17.57 % -5.24 %
Share Holder 3 Year Equity Growth Per Share 9.16 % 37.85 % 9.16 % 66.6 % 17.06 %
Share Holder 5 Year Equity Growth Per Share 13.89 % 93.34 % 13.89 % 128.49 % 72.84 %
Share Holder 10 Year Equity Growth Per Share 241.78 % 354.67 % 241.78 % 166.2 % 172.25 %
Dividend Per Share Growth -2.44 % - -2.44 % 9.12 % 5.53 %
Dividend 3 Year Growth Per Share 4.79 % - 4.79 % 23.08 % 17.87 %
Dividend 5 Year Growth Per Share 4.14 % - 4.14 % 29.8 % 32.84 %
Dividend 10 Year Growth Per Share 74.3 % - 74.3 % 91.97 % 97.25 %
Debt Growth 26.65 % - 26.65 % -44.68 % -1.2 %
Free Cash Flow Growth 45.25 % 73.93 % 45.25 % 130 % -33.32 %
Updated On 30 Sep 2024 31 Dec 2024 30 Sep 2024 30 Jun 2024 31 Dec 2024
Profitability
BDXA ISRG BDX ALC RMD WST
Gross Profit Margin TTM 44.5 % 67.09 % 44.5 % 55.55 % 58.53 % 35.27 %
Return on Assets TTM 2.75 % 12.88 % 2.75 % 3.61 % 17.36 % 32.23 %
Return on Equity TTM 5.86 % 15.52 % 5.86 % 5.22 % 25.18 % 24.03 %
Return on Capital Employed TTM 5.05 % 13.9 % 5.05 % 5.26 % 24.33 % 64.01 %
Net Income Per EBT TTM 89.01 % 88.31 % 89.01 % 83.9 % 83.26 % 80.45 %
EBT Per Ebit TTM 71.19 % 114.09 % 71.19 % 88.24 % 97.84 % 104.23 %
EBIT Per Revenue TTM 11.33 % 28.2 % 11.33 % 15.24 % 32.1 % 19.65 %
Cash Flow To Debt Ratio TTM 17.12 % - 17.12 % 40.46 % 196.83 % -
Receivables Turnover TTM 6.89 6.46 6.89 5.34 5.53 5.08
Payables Turnover TTM - 10.39 - 5.24 9.36 8.02
Inventory Turnover TTM 3.11 1.85 3.11 1.88 2.41 4.55
Fixed Asset Turnover TTM 313.98 % 181.6 % 313.98 % 202.43 % 729.93 % -
Asset Turnover TTM 38.31 % 45.34 % 38.31 % 32.01 % 66.36 % 195.63 %
Operating Cash Flow Per Share TTM 11.44 7.64 11.44 4.24 11.27 9.36
Free Cash Flow Per Share TTM 8.98 4.88 8.98 3.26 10.66 4.76
Cash Per Share TTM 236.81 % 1261.9 % 236.81 % 285.19 % 635.71 % 704.98 %
Operating Cash Flow Sales Ratio TTM 15.81 % 31.34 % 15.81 % 21.17 % 32.92 % 22.86 %
Free Cash Flow Operating Cash Flow Ratio TTM 78.51 % 63.9 % 78.51 % 76.82 % 94.64 % 50.83 %
Cash Flow Coverage Ratios TTM 17.12 % - 17.12 % 40.46 % 196.83 % -
Price To Free Cash Flows Ratio TTM 19.72 105.28 19.14 27.32 26.03 50.01
Price To Operating Cash Flows Ratio TTM 15.58 67.1 15.12 21.01 24.65 25.56
Price Cash Flow Ratio TTM 15.58 67.1 15.12 21.01 24.65 25.56
Income Statement (TTM)
BDXA ISRG BDX ALC RMD WST
Revenue $20.18B $8.35B $20.18B $9.91B $5.15B $2.89B
Gross Profit $9.13B $5.63B $9.13B $5.51B $3.05B $1B
Gross Profit Ratio 45.22% 67.46% 45.22% 55.61% 59.36% 34.51%
EBITDA $4.82B $2.81B $4.82B $2.68B $1.69B $0.74B
Net Income $1.71B $2.32B $1.71B $1.02B $1.4B $0.49B
EPS Diluted 5.86 6.42 5.86 2.05 - 6.69
Balance Sheet (MRQ)
BDXA ISRG BDX ALC RMD WST
Long Term Debt $17.94B $0.11B $17.94B $4.97B $0.84B $0.29B
Total Liabilities $31.4B $2.31B $31.4B $8.79B $2.01B $0.96B
Total Equity $25.89B $16.53B $25.89B $21.55B $4.86B $2.68B
Total Investments $0.45B $7.05B $0.45B $0.91B $0.17B $0.2B
Total Debt $20.11B $0.15B $20.11B $5.14B $0.87B $0.31B
Total Assets $57.29B $18.84B $57.29B $30.35B $6.87B $3.64B
Cash Flow Statement (TTM)
BDXA ISRG BDX ALC RMD WST
Net Income $1.71B $2.34B $1.71B $1.02B $1.4B $0.49B
Inventory $0.1B $-0.83B $0.1B $-0.05B $-0.08B $0.04B
Dividends Paid $-1.1B $0B $-1.1B $-0.13B $-0.31B $-0.06B
Operating Cash Flow $3.8B $2.42B $3.8B $2.08B $1.75B $0.65B
Capital Expenditure $-0.73B $-1.11B $-0.73B $-0.67B $-0.09B $-0.38B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 87.87
ANGO AngioDynamics, Inc. 8.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 141.35
ATRC AtriCure, Inc. 34.41
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AZTA Azenta, Inc. 32.34
BAX Baxter International Inc. 21.96
BDX Becton, Dickinson and Company 176.37
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 13.5
BLFS BioLife Solutions, Inc. 20.805
COO The Cooper Companies, Inc. 70.87
DXR Daxor Corporation 9.45
EKSO Ekso Bionics Holdings, Inc. 3.49
FEMY Femasys Inc. 0.8196
GCTK GlucoTrack, Inc. 6.23
Unlock